prof. dr. Franki Speleman
work address
C. Heymanslaan 10, ingang 34 (MRB)
9000 Gent
9000 Gent
ORCID iD
https://orcid.org/0000-0002-6628-8559
1 – 10 of 604
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- A high-throughput 3’ UTR reporter screening identifies microRNA interactomes of cancer genes
- Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients
- Vehicle development, pharmacokinetics and toxicity of the anti-invasive agent 4-fluoro-3’,4’,5’-trimethoxychalcone in rodents
- The mutational landscape of MYCN, Lin28b and ALKF1174L driven murine neuroblastoma mimics human disease
- 2017
- In-house developed 15-gene sequencing panel for acute myeloid leukemia and myelodysplasia allows robust detection of genetic defects including FLT3-ITD and CEBPA mutations
- In-house developed 15-gene sequencing panel for acute myeloid leukemia and myelodysplasia allows robust detection of genetic defects including FLT3-ITD and CEBPA mutations
- The HBP1 tumor suppressor is a negative epigenetic regulator of MYCN driven neuroblastoma through interaction with the PRC2 complex
- Genomic Amplifications and Distal 6q Loss are Novel Markers for Poor Survival in High-risk Neuroblastoma Patients
- Identification of novel, rare markers for poor survival in high-risk neuroblastoma patients by merging and reanalysing existing datasets
- Shallow Whole Genome Sequencing on Circulating Cell-Free DNA Allows Reliable Noninvasive Copy-Number Profiling in Neuroblastoma Patients